N-methyl-D-aspartate receptor (extrasynaptic) (eNMDAR)

Extrasynaptic N-methyl-D-aspartate receptors (eNMDARs) are a subpopulation of ionotropic glutamate receptors located on the neuronal plasma membrane outside the synaptic cleft (Hardingham & Bading, 2010). While synaptic NMDARs are essential for learning, memory, and neuronal survival, eNMDARs are predominantly linked to excitotoxicity and the induction of cell death pathways (Bading, 2017). Activation of these receptors, typically by glutamate spillover or elevated ambient glutamate, triggers signaling cascades that inhibit pro-survival transcription factors like CREB and promote mitochondrial dysfunction (Parsons & Raymond, 2014). This pathological signaling is implicated in the progression of various neurological disorders, including Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (Lipton, 2006). Therapeutic intervention focuses on selectively inhibiting eNMDAR activity to prevent neurodegeneration while maintaining normal synaptic transmission (Parsons & Raymond, 2014). Drugs such as memantine are designed to preferentially block the chronically open eNMDAR channels associated with disease states (Lipton, 2006).

Other names

Extrasynaptic NMDA receptorNon-synaptic NMDA receptorGluN2B-containing NMDA receptoreNMDAR

Uncompetitive antagonism and allosteric modulation aimed at blocking the ion channel pore or reducing receptor activity specifically under conditions of pathological glutamate elevation (Lipton, 2006; Parsons & Raymond, 2014).